Send us Feedback

Orchid Cellmark (ORCH)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Lab Corp (LH) Extends Tender for Orchid Cellmark (ORCH)
StreetInsider.com  Dec 1  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Lab+Corp+%28LH%29+Extends+Tender+for+Orchid+Cellmark+%28ORCH%29/6987575.html for the full story.
LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
Benzinga  Nov 15  Comment 
Laboratory Corporation of America® Holdings (NYSE: LH) today announced that LabCorp is extending until 5:00 p.m., New York City time, on November 30, 2011 LabCorp's previously announced cash tender offer for all outstanding shares of the common...
Laboratory Corp. (LH) Extends $2.80/Share Tender for Orchid Cellmark (ORCH)
StreetInsider.com  Sep 12  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Laboratory+Corp.+%28LH%29+Extends+%242.80Share+Tender+for+Orchid+Cellmark+%28ORCH%29/6777368.html for the full story.
Gabe Hoffman’s Accipiter Capital Scores Big With Orchid Cellmark Investment
Wall Street Sector Selector  May 9  Comment 
Accipiter Capital is an activist hedge fund founded by Gabe Hoffman in 2002. Prior to starting Accipiter, Hoffman worked at Welch Capital Partners covering healthcare stocks. The most distinctive characteristic of Accipiter is that it is an...
Unusual 11 Mid-Day Movers 04/06: (ORCH) (BLTI) (ABAT) Higher; (AMSC) (ONSM) (DYNT) Lower
StreetInsider.com  Apr 6  Comment 
American Superconductor (Nasdaq: AMSC) 44.4% LOWER; cuts guidance: now sees fourth-quarter sales less than $42 million, versus the consensus of $119.13 million. Also sees a quarterly net loss on both GAAP and non-GAAP basis. Sees FY10 sales to...
Morning Movers 04/06: (ORCH) (SIMO) (BLTI) (HILL) Higher; (AMSC) (DYNT) Lower
StreetInsider.com  Apr 6  Comment 
Notable Mergers and Acquisitions of the Day 04/06: (LH)/(ORCH) (G) (MSCC)/(AMLJ) (CLH)
StreetInsider.com  Apr 6  Comment 
Laboratory Corporation of America Holdings (NYSE: LH) and Orchid Cellmark Inc. (Nasdaq: ORCH) announced that they have entered into an agreement whereby Lab Corp will acquire Orchid Cellmark for $2.80 per share in cash, or total consideration of...
Movers & Shakers: Wednesday’s biggest advancers and decliners
MarketWatch  Apr 6  Comment 
MarketWatch’s rundown of shares making noteworthy moves in Wednesday trading.
LabCorp to Acquire Orchid Cellmark
TheStreet.com  Apr 6  Comment 
BURLINGTON, North Carolina (TheStreet) -- Laboratory Corp. of America said Wednesday it agreed to buy Orchid Cellmark for $2.80 a share, or about $85.4 million. Shares of Orchid, a DNA testing services company, closed Tuesday at $2 a...
LabCorp to acquire Orchid Cellmark for $85 mln in cash
Reuters  Apr 6  Comment 
LabCorp to Acquire Orchid Cellmark
Forbes  Apr 6  Comment 
Laboratory Corp. buying Orchid for $85.4 million
MarketWatch  Apr 6  Comment 
U.K.'s Child Maintenance and Enforcement Commission Awards Orchid Cellmark Exclusive DNA Paternity Testing Contract
Globe Newswire  Jan 18  Comment 
ABINGDON, United Kingdom and PRINCETON, N.J., Jan. 18, 2011 (GLOBE NEWSWIRE) -- Orchid Cellmark (Nasdaq:ORCH), a leading worldwide provider of identity DNA testing services, today announced it has executed a multi-year contract with the U.K. Child
Bearish moments at NASDAQ: (ORCH, CLWT, GRNB, CNST, PSBH)
Penny Stock DD  Dec 30  Comment 
Orchid Cellmark, Inc. (NASDAQ:ORCH) reported the fall of 8.61% to close at $1.91 with overall traded volume of 68,799 shares in the last trading day. The share price is at its overbought level with relative strength index of 63.37 times till its...




more ▼WIKI ANALYSIS
 
TOP CONTRIBUTORS
Sr. Director
Grant Zeng
www.zacks.com

Founded in 1995 and headquartered in New Jersey, Orchid Cellmark Inc. (ORCH) is a leading provider of DNA testing services for human identity and agricultural applications in the U.S. and the U.K. The company utilizes its innovative genetic analysis technology to generate genetic profile information by analyzing an organism's unique genetic identity. The company provides DNA testing services for forensic, family relationship, and security applications in the human identity area to government agencies and private individuals as well as DNA testing services for selective trait breeding and traceability in agricultural applications for government agencies and commercial companies. Orchid's strong market position in these segments is attributable to the company's accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the world-renowned Cellmark brand that has been associated with exceptional quality, reliability and customer service for nearly two decades. It was formerly known as Orchid Biosciences Inc. and changed its name to Orchid Cellmark, Inc. in 2005. As of December 31, 2006, the company had 403 employees.




References

Retrieved from "http://www.wikinvest.com/stock/Orchid_Cellmark_(ORCH)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki